Solventum

Solventum Corporation, an American health care company, emerged on April 1, 2024, as a standalone entity spun off from the industrial giant 3M. The move marked a strategic shift for 3M, which had long been known for its diversified portfolio ranging from Post-it notes to advanced materials. Solventum focuses on medical and surgical supplies, oral care, health information systems, and filtration, aiming to streamline innovation in these niches. While it inherits a legacy of trusted brands, the new company faces the challenge of establishing its own corporate identity and growth trajectory outside the 3M umbrella.

With a workforce of over 20,000 and an annual revenue exceeding $8 billion, Solventum positions itself as a dedicated player in the health care sector. The company's leadership is navigating a significant transformation, including responding to pressure from activist investor Trian Fund Management. In August 2026, Solventum announced its intention to separate its Health Information Systems business, a move aimed at sharpening its focus as a pure-play MedTech firm. The company reported strong Q2 2026 results, with revenue of US$2.209 billion and net income of US$92 million, beating analyst expectations and prompting a raised full-year profit forecast. [edit]